senolytic peptide foxo4-dri human study The disordered p53 transactivation domain is the target of FOXO4 and the compound Supplements and Powders dihexa clinical trials humans Size:6 x 10mg/10mg
SKU: 51344273979
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 16 - Sep 21